Rewriting human health,

one cell at a time

Biomedical innovation and a new generation of cures through deterministic cell programming

Cell coding platform

Our platform has the ability to create any human cell type and to manufacture it at scale with precision and consistency. 

bitbio-platform_diagram-horizontal-no_BG-V2.1 bitbio-platform_diagram-vertical-no_BG-min

Therapeutics

Biology is our software, cells are our cures. Every cell type that we create has the potential to give rise to multiple next generation therapies.

ioCells

Deterministically programmed human iPSC-derived cells for research and drug discovery

iocells_vial_radial_0

Latest news

bit.bio Raises $30 Million Led by M&G Investments Press Release
bit.bio Raises $30 Million Led by M&G Investments 16.12.2024
Published by bit.bio
Read now
Insights from iGEM Judge Andreas: Exploring Synthetic Biology, Innovation, and Future Bioengineers News
Insights from iGEM Judge Andreas: Exploring Synthetic Biology, Innovation, and Future Bioengineers 17.10.2024
Published by bit.bio
Read now
bit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell Programming Technology Press Release
bit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell Programming Technology 16.10.2024
Published by bit.bio
Read now
bit.bio featured in Tech Nation's Future Fifty Report Article
bit.bio featured in Tech Nation's Future Fifty Report 09.10.2024
Published by Tech Nation
Read now